查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2030090

合約研究機構市場－全球產業規模、佔有率、趨勢、機會、預測：按服務、應用、地區和競爭格局分類，2021-2031年

Contract Research Organization Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Service, By Application, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球合約研究組織 (CRO) 市場預計將從 2025 年的 527.2 億美元成長到 2031 年的 706.9 億美元，複合年成長率為 5.01%。

合約研究組織 (CRO) 為醫療設備、生技和製藥業提供至關重要的研發外包服務，包括法規支援、資料管理和臨床試驗監管。這一市場擴張的主要驅動力是生命科學公司將研發外包以降低成本並利用專業知識的趨勢日益成長。全球臨床試驗的數量和複雜性不斷增加，尤其是在特定治療領域，進一步推動了這項需求。臨床研究專業人員協會 (ACRP) 最近進行的一項調查（調查時間為 2024 年底至 2025 年初）顯示，超過 735 名專業人員表示數據品質有所提高。阻礙市場進一步成長的主要障礙是臨床研究領域合格人員的持續全球短缺。這種短缺影響了各項關鍵職位的履行能力，並可能導致專案延期。此外，由於不斷變化的區域監管環境以及申辦者對品質和執行速度日益成長的期望，CRO 還面臨巨大的營運挑戰。

市場概覽
預測期 2027-2031
市場規模：2025年 527.2億美元
市場規模：2031年 706.9億美元
複合年成長率：2026-2031年 5.01%
成長最快的細分市場 初始開發服務
最大的市場 北美洲

市場促進因素

全球合約研究組織 (CRO) 市場的主要驅動力是生物製藥公司研發投入的持續成長。儘管一些領先的製藥公司調整了 2025 會計年度的研發預算以最佳化產品線，但整個產業，尤其是生物技術公司，仍然堅定不移地致力於創新。例如，臨床研究機構 ICON 於 12 月發布的一項針對 2025 年上半年的調查顯示，75% 的全球生技公司計劃在未來幾年增加研發投入。這種持續的投資正在推動對外部專業服務的需求，使生物製藥公司能夠獲得各種專業知識和技術工具，而無需承擔內部研發相關的高成本。現代臨床試驗數量和複雜性的激增也是推動市場發展的主要因素。現今的藥物研發需要複雜的調查方法、標靶治療和複雜的試驗設計，因此專業的營運技能至關重要。臨床研究專業人員協會 (ACRP) 在 2025 年 10 月發布的報告《了解 2025 年大型臨床實驗中心面臨的挑戰》中指出，35% 的臨床實驗中心認為試驗的複雜性是其面臨的最大障礙，這一趨勢自 2024 年以來持續存在。這種複雜性，加上對多樣化受試者群體和國際招募日益成長的需求，迫使製藥和生物技術公司與擁有必要全球基礎設施和治療專業知識的合約研究組織 (CRO) 合作。臨床研究專業人員協會 (ACRO) 在 2025 年初發布的數據進一步佐證了這一點，數據顯示其成員在 2024 年參與了 8,854 項研究。

市場挑戰

全球臨床研究產業持續存在的專業人才短缺是限制全球CRO市場成長的主要障礙。專業人才的匱乏直接影響多個關鍵職位的營運效率，可能導致專案延期和臨床試驗延遲。隨著全球臨床試驗數量和複雜性的增加，CRO面臨越來越大的壓力，需要為每個專案配備充足的人員。人才短缺從根本上限制了CRO按計畫啟動和完成試驗的能力，從而限制了整體市場成長。臨床研究專業人員協會（ACRP）2025年的一項調查凸顯了這個問題，調查顯示，52%的臨床研究專業人員認為，與5-10年前相比，招募和留住人才更加困難。持續存在的人才獲取和留用挑戰正在削弱CRO高效管理現有工作量和訂單新計畫的能力，最終阻礙了市場的整體擴張。

市場趨勢

機器學習 (ML) 和人工智慧 (AI) 在臨床營運中的廣泛應用，是全球 CRO 市場的突破性趨勢。這些技術進步提高了試驗多個階段的準確性和效率，從受試者招募和方案製定到風險評估和數據評估。透過利用 AI 和 ML 演算法，CRO 可以快速分析大量資料集，捕捉細微趨勢，並產生預測模型，從而改善營運流程。特別值得一提的是，《應用臨床試驗在線》(Applied Clinical Trials Online) 2025 年 6 月的一份報告指出，超過三分之一 (35.2%) 的 CRO 和申辦方公司將部分或全部整合 AI/ML 到其臨床試驗運營中，從而能夠為生物技術和申辦方公司將部分或全部整合 AI/ML 到其臨床試驗運營中，從而能夠為生物技術和快速製藥客戶提供經濟高效且快速的藥物開發服務。另一個顯著影響 CRO 產業結構的關鍵趨勢是混合型和分散式臨床試驗框架的持續發展。這些創新模式突破了傳統的完全基於研究中心的模式，整合了本地醫療服務提供者的參與、遠端醫療和遠端監測，提高了受試者的便利性和可近性。這種演變促使合約研究組織（CRO）相應地調整其技術和營運結構，以擴大患者招募的地域範圍（這對居住分散的人群和罕見疾病尤其有利），並提高患者留存率。反映這一轉變的是，ACRO 2025 年 7 月發表的一篇報導詳細介紹了其 2025 年基於風險的品質控制（RBQM）調查，指出 96% 的臨床試驗目前至少包含一項基於風險的品管要素。這使得遠端監督和集中監查成為標準做法，並需要專業技能來妥善管理複雜的資料流和多樣化的法規環境。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球合約研究機構市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 以服務為基礎的各項服務（早期開發服務、臨床研究服務、測試服務、諮詢服務、資料管理服務）
    • 依應用領域（腫瘤學、中樞神經系統、循環系統、呼吸系統、感染疾病、自體免疫疾病、其他）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美合約研究機構市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲合約研究機構市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區合約研究機構市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲合約研究機構市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲合約研究機構市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球合約研究機構市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • GE HealthCare Technologies Inc.
  • Abbott Laboratories
  • Agilent Technologies Inc.
  • PerkinElmer Inc.
  • Standard BioTools Inc.
  • Illumina Inc.
  • Bio-Rad Laboratories Inc.
  • Cepheid Inc.
  • Thermo Fisher Scientific Inc.
  • Qiagen NV

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 7311

The Global Contract Research Organization (CRO) Market is anticipated to expand from USD 52.72 Billion in 2025 to USD 70.69 Billion by 2031, reflecting a compound annual growth rate of 5.01%. CROs provide vital outsourced research functions-including regulatory assistance, data handling, and clinical trial oversight-to the medical device, biotechnology, and pharmaceutical sectors. This expansion is largely fueled by the growing trend of life sciences companies outsourcing their research and development to achieve cost savings and leverage niche expertise. The escalating number and intricacy of clinical trials worldwide, particularly within specialized therapeutic fields, additionally boost this demand, with a recent Association of Clinical Research Professionals (ACRP) survey from late 2024 to early 2025 showing that over 735 professionals observed enhancements in data quality.\nA major obstacle hindering the broader growth of this market is the ongoing worldwide shortage of qualified talent in the clinical research field. This deficit affects the operational capabilities of various essential roles and introduces the risk of delayed projects. Furthermore, CROs face significant operational difficulties due to constantly changing regulatory landscapes across different regions, along with growing expectations from sponsors for unwavering quality and rapid execution.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 52.72 Billion
Market Size 2031USD 70.69 Billion
CAGR 2026-20315.01%
Fastest Growing SegmentEarly Phase Development Services
Largest MarketNorth America

Market Driver

A primary catalyst for the Global Contract Research Organization Market is the continuous rise in research and development (R&D) expenditures by biopharmaceutical firms. While certain major pharmaceutical companies adjusted their 2025 R&D budgets to streamline pipelines, the broader industry-especially biotech entities-maintains a steadfast dedication to innovation. For example, a mid-year 2025 survey released in December by the clinical research organization ICON revealed that 75% of global biotech firms intend to boost their R&D spending over the next couple of years. This sustained investment drives the need for external specialist services, offering biopharma companies access to varied expertise and technological tools without the heavy overhead of internal development.\nThe market is also heavily propelled by the surging volume and intricacy of modern clinical trials. Today's drug development requires advanced methodologies, targeted treatments, and complex trial designs, necessitating specialized operational skills. Highlighting this, the Association of Clinical Research Professionals (ACRP) noted in its October 2025 report, 'Unveiling 2025's Biggest Site Challenges,' that 35% of sites viewed trial complexity as their main hurdle, a continuing trend from 2024. This intricacy, alongside the demand for diverse participant populations and international recruitment, pushes pharmaceutical and biotech companies to collaborate with CROs equipped with the required global infrastructure and therapeutic knowledge, supported by early 2025 data from the Association of Clinical Research Organizations (ACRO) showing its members participated in 8,854 studies during 2024.

Market Challenge

The ongoing global deficit of specialized talent in the clinical research industry poses a substantial barrier to the advancement of the Global Contract Research Organization Market. This lack of skilled professionals directly hampers operational efficiency across multiple critical positions, which can extend project timelines and cause setbacks in clinical trials. As worldwide clinical studies grow in both quantity and intricacy, Contract Research Organizations are experiencing intensified pressure to adequately staff their initiatives.\nThis scarcity of personnel fundamentally restricts the capacity of Contract Research Organizations to launch and finalize studies on schedule, consequently constraining the overall growth of the market. Highlighting this issue, a 2025 survey by the Association of Clinical Research Professionals (ACRP) revealed that 52% of clinical research professionals found recruiting and keeping staff more difficult compared to five to ten years ago. The persistent struggle to build and retain an expert workforce compromises the ability of CROs to efficiently manage their existing workload and accept new projects, ultimately stalling the market's broader expansion.

Market Trends

The extensive adoption of Machine Learning (ML) and Artificial Intelligence (AI) in clinical operations stands out as a revolutionary trend in the global Contract Research Organization market. These technological advancements boost the accuracy and productivity of multiple trial stages, ranging from patient recruitment and protocol creation to risk assessment and data evaluation. By utilizing AI and ML algorithms, CROs can swiftly analyze massive datasets, spot subtle trends, and generate predictive models that refine operational processes. Notably, Applied Clinical Trials Online reported in June 2025 that over one-third (35.2%) of CROs and sponsor firms had partially or fully integrated AI/ML into their trial operations, enabling them to deliver cost-efficient, accelerated drug development services to biotech and pharma clients.\nAnother crucial trend significantly shaping the CRO landscape is the continued advancement of hybrid and decentralized clinical trial frameworks. These innovative models transition away from traditional, fully site-based studies by integrating local healthcare provider involvement, telehealth, and remote monitoring to boost participant convenience and accessibility. This evolution expands the geographic possibilities for patient enrollment-especially beneficial for scattered populations or rare conditions-and improves retention rates, prompting CROs to adjust their technological and operational structures accordingly. Reflecting this shift, a July 2025 article detailing ACRO's 2025 RBQM survey noted that 96% of trials now incorporate at least one risk-based quality management element, making remote oversight and centralized monitoring standard practices that require specialized skills to navigate complex data flows and diverse regulatory environments.

Key Market Players

  • GE HealthCare Technologies Inc.
  • Abbott Laboratories
  • Agilent Technologies Inc.
  • PerkinElmer Inc.
  • Standard BioTools Inc.
  • Illumina Inc.
  • Bio-Rad Laboratories Inc.
  • Cepheid Inc.
  • Thermo Fisher Scientific Inc.
  • Qiagen N.V.

Report Scope

In this report, the Global Contract Research Organization Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Contract Research Organization Market , By Service

  • Early Phase Development Services
  • Clinical Research Services
  • Laboratory Services
  • Consulting Services
  • Data Management Services

Contract Research Organization Market , By Application

  • Oncology
  • Central Nervous System
  • Cardiovascular
  • Respiratory
  • Infectious Diseases
  • Autoimmune Disorders
  • Others

Contract Research Organization Market , By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Contract Research Organization Market .

Available Customizations:

Global Contract Research Organization Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Contract Research Organization Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Service (Early Phase Development Services, Clinical Research Services, Laboratory Services, Consulting Services, Data Management Services)
    • 5.2.2. By Application (Oncology, Central Nervous System, Cardiovascular, Respiratory, Infectious Diseases, Autoimmune Disorders, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Contract Research Organization Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Service
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Contract Research Organization Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Service
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Contract Research Organization Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Service
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Contract Research Organization Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Service
        • 6.3.3.2.2. By Application

7. Europe Contract Research Organization Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Service
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Contract Research Organization Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Service
        • 7.3.1.2.2. By Application
    • 7.3.2. France Contract Research Organization Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Service
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Contract Research Organization Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Service
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Contract Research Organization Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Service
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Contract Research Organization Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Service
        • 7.3.5.2.2. By Application

8. Asia Pacific Contract Research Organization Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Service
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Contract Research Organization Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Service
        • 8.3.1.2.2. By Application
    • 8.3.2. India Contract Research Organization Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Service
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan Contract Research Organization Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Service
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea Contract Research Organization Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Service
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Contract Research Organization Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Service
        • 8.3.5.2.2. By Application

9. Middle East & Africa Contract Research Organization Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Service
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Contract Research Organization Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Service
        • 9.3.1.2.2. By Application
    • 9.3.2. UAE Contract Research Organization Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Service
        • 9.3.2.2.2. By Application
    • 9.3.3. South Africa Contract Research Organization Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Service
        • 9.3.3.2.2. By Application

10. South America Contract Research Organization Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Service
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Contract Research Organization Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Service
        • 10.3.1.2.2. By Application
    • 10.3.2. Colombia Contract Research Organization Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Service
        • 10.3.2.2.2. By Application
    • 10.3.3. Argentina Contract Research Organization Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Service
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Contract Research Organization Market : SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. GE HealthCare Technologies Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Abbott Laboratories
  • 15.3. Agilent Technologies Inc.
  • 15.4. PerkinElmer Inc.
  • 15.5. Standard BioTools Inc.
  • 15.6. Illumina Inc.
  • 15.7. Bio-Rad Laboratories Inc.
  • 15.8. Cepheid Inc.
  • 15.9. Thermo Fisher Scientific Inc.
  • 15.10. Qiagen N.V.

16. Strategic Recommendations

17. About Us & Disclaimer